With Vtama's success in relieving itching, Dermavant eyes FDA filing in atopic dermatitis
Fierce Pharma
OCTOBER 11, 2023
In the race to develop nonsteroidal topical treatments for autoimmune skin conditions, Dermavant is charging toward the finish line—again. Dermavant has presented evidence that Vtama provides immediate and long-term relief from the severe itch condition pruritus, the most prevalent symptom of atopic dermatitis.
Let's personalize your content